Pharmaceuticals giant Roche this week reported a 28 per cent fall
in net profits for the first half of the year. The Swiss company
saw net profit fall from SF2.5billion to SF1.8billion, partly due
to a 39 per cent drop in operating...
With an overall drop of 3 per cent in sales for this year's first
half, Degussa refutes expectations of an upturn in the second half.
Restructuring of core businesses and divesting non-core operations
will continue in a drive...
US-based Lifeway Foods reported second quarter revenues of $3
million (€3.03), an increase of 9 per cent on the same period last
year. The success continues the strong trend seen this year by the
functional foods manufacturer.
The German pharmaceuticals group reports that sales in the first
six months of 2002 rose 21 per cent on the previous year to €3.7
billion while operating income showed growth of 48 per cent to €495
million. Business in the US was...
The manufacturer of functional food ingredients derived from rice
bran reported lower revenues and net income for the second quarter
compared with the same period last year, but said sales in domestic
markets have grown.
The Swiss food giant has confirmed its interest in some of
Novartis' functional foods, part of the unit put up for sale
earlier this year. Analysts speculate that the food group could
easily afford to buy the drug company's...
Energy drink maker Hansen Natural reported record gross and net
sales for the second quarter ended June 30, 2002. The company
attributed strong sales to its core beverage lines and new product
The producer of plant-based dairy alternatives shrugs off flat
sales to post a strong rise in profits in the first quarter of
fiscal 2003 as its restructuring and expansion programme begins to
Zila, the US-based pharmaceutical and nutraceutical producer, said
it remained confident that EBITDA would grow significantly next
year after major restructuring of the business during the final
quarter of 2002.